Clinical Trials Directory

Trials / Completed

CompletedNCT03139201

Clinical Performance of the OxyAqua Daily Disposable Silicone Hydrogel Soft Contact Lens

A Prospective Randomized Controlled Study to Evaluate the Clinical Performance of OxyAqua Silicone Hydrogel Soft Contact Lens

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Visco Vision Inc. · Industry
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to demonstrate that the OxyAqua silicone hydrogel soft contact lens could be prescribed as a supportive care for myopes.

Detailed description

This is a double blind randomized control study to evaluate a daily disposable contact lens. It is planned to have 30 evaluable subjects at least divided evenly among 3 independent PIs from one hospital. Each PI will enroll 12 subjects at least. The ration of evaluable test subjects to control subjects will be 2 to 1. The study lens will be dispensed randomly to subjects who have normal ocular health and conform to a set of criteria. It is necessary to wear the lens 8 hours a day and 5 days a week at least and follow up for one month (30 days). Data will be collected at baseline, 1 week, 2 week and 4 week of daily disposable modality including Adverse Reactions, Slit-lamp findings and Symptoms, Problems, and Complaints, vision acuity, keratometry change and reason for discontinuation.

Conditions

Interventions

TypeNameDescription
DEVICEOxyAquaOxyAqua (olifilcon D) silicone hydrogel soft contact lens
DEVICESi-HySi-Hy (oliflcon B) silicone hydrogel soft contact lens

Timeline

Start date
2016-09-21
Primary completion
2016-12-08
Completion
2016-12-08
First posted
2017-05-03
Last updated
2017-05-03

Source: ClinicalTrials.gov record NCT03139201. Inclusion in this directory is not an endorsement.